```html

Huntington’s Disease – Comprehensive Medical Guide

Overview

Huntington’s disease (HD) is a progressive, neurodegenerative disorder caused by an abnormal expansion of CAG repeats in the HTT gene on chromosome 4. The mutant huntingtin protein gradually damages nerve cells in the brain, leading to a triad of motor, cognitive, and psychiatric disturbances.

Who it affects: HD is inherited in an autosomal‑dominant pattern, meaning a child has a 50 % chance of inheriting the mutation from an affected parent. Symptoms typically appear in mid‑adulthood, but the disease can manifest anywhere from childhood (juvenile HD) to the 70s.

Prevalence: Approximately 5–10 per 100,000 individuals of European descent carry the disease‑causing mutation, translating to about 30,000‑40,000 people in the United States and 12,000 in the United Kingdom.<sup>[1] CDC, 2023</sup> Prevalence is lower in Asian and African populations, likely reflecting differences in allele frequency.

Symptoms

Symptoms evolve over a 10–30‑year disease course. Below is a comprehensive list, grouped by system.

Motor Symptoms

• Chorea: Involuntary, jerky, dance‑like movements that begin in the face, trunk, and limbs.
• Dystonia: Sustained muscle contractions causing abnormal postures.
• Bradykinesia: Slowed voluntary movements, often mistaken for Parkinsonian features.
• Impaired coordination (ataxia): Unsteady gait, frequent falls.
• Difficulty swallowing (dysphagia) and speech (dysarthria): Leads to weight loss and aspiration risk.
• Eye movement abnormalities: Impaired smooth pursuit.

Cognitive Symptoms

• Executive dysfunction: Trouble planning, multitasking, and problem‑solving.
• Memory impairment: Particularly working memory and retrieval of recent events.
• Reduced insight (anosognosia): Patients may be unaware of their deficits.
• Slowed information processing.

Psychiatric / Behavioral Symptoms

• Depression: Often the earliest psychiatric sign.
• Anxiety & irritability.
• Obsessive‑compulsive behaviors.
• Psychosis: Hallucinations or delusional thinking in later stages.
• Risk‑taking or self‑harm behaviors.
• Apathy and social withdrawal.

Other Systemic Features

• Weight loss: Due to increased energy expenditure, dysphagia, and metabolic changes.
• Sleep disturbances: Insomnia, restless leg syndrome, or REM sleep behavior disorder.
• Autonomic dysfunction: Incontinence, orthostatic hypotension.

Causes and Risk Factors

HD is caused by a pathogenic expansion of CAG trinucleotide repeats in the HTT gene. Normal alleles contain fewer than 35 repeats; disease‑causing alleles have ≥36 repeats. The larger the repeat length, the earlier the disease onset (inverse correlation).

Genetic Cause

• Autosomal‑dominant inheritance – each child of an affected parent has a 50 % chance of inheriting the mutation.
• De novo mutations are rare (<1 % of cases).

Risk Factors

• Family history: Having a first‑degree relative with HD is the strongest risk factor.
• Number of CAG repeats: 36‑39 repeats → reduced penetrance; ≥40 repeats → full penetrance.
• Sex: No significant difference in prevalence, though some studies suggest slightly earlier onset in men.
• Ethnicity: Higher carrier frequency in people of European descent.

Diagnosis

Diagnosis is based on a combination of clinical assessment, family history, and genetic testing.

Clinical Evaluation

• Neurological exam focusing on chorea, coordination, and gait.
• Cognitive testing (e.g., MoCA, Mini‑Mental State Exam).
• Psychiatric assessment for mood and behavior changes.

Genetic Testing

A blood sample is analyzed for CAG repeat length in the HTT gene. Testing is definitive and is recommended when:

• There is a known affected relative.
• Typical motor and psychiatric signs appear in the appropriate age range.

Pre‑test counseling is essential because results have profound emotional and familial implications.<sup>[2] NIH Genetic Testing Registry, 2022</sup>

Imaging & Other Tests (supportive)

• MRI: Shows caudate nucleus atrophy and ventricular enlargement, especially in later stages.
• CT scan: Less sensitive, used when MRI contraindicated.
• Neuropsychological testing: Baseline cognitive profile for monitoring progression.

Treatment Options

There is currently no cure for HD; treatment aims to manage symptoms, improve quality of life, and support caregivers.

Pharmacologic Therapies

• Tetrabenazine (Xenazine) or Deutetrabenazine (Austedo): First‑line for chorea; works by depleting dopamine.
• Antipsychotics (e.g., risperidone, olanzapine): Help control severe chorea, psychosis, or irritability.
• Antidepressants (SSRIs, SNRIs): Treat depression, anxiety, and obsessive‑compulsive symptoms.
• Mood stabilizers (e.g., valproic acid, lamotrigine): For mood swings or aggression.
• Amantadine: May modestly improve chorea and rigidity.

Procedural & Supportive Interventions

• Physical therapy: Improves balance, gait, and maintains muscle strength.
• Occupational therapy: Adaptive equipment for daily living (e.g., weighted utensils, grab bars).
• Speech-language therapy: Strategies for dysarthria and safe swallowing.
• Psychotherapy & counseling: Cognitive‑behavioral therapy for depression and anxiety.
• Clinical trials: Ongoing research into gene‑silencing (e.g., antisense oligonucleotides) and CRISPR‑based approaches.

Lifestyle Modifications

• Regular aerobic exercise (30 min, 3‑5 times/week) can slow motor decline.
• Balanced diet rich in antioxidants and adequate calories to counteract weight loss.
• Sleep hygiene: consistent bedtime, limiting caffeine, treating sleep apnea.
• Avoid alcohol and sedating medications that exacerbate balance problems.

Living with Huntington’s Disease

Managing HD requires a multidisciplinary approach that involves patients, families, and care teams.

Practical Daily‑Management Tips

• Establish routines: Predictable schedules reduce anxiety and aid memory.
• Home safety: Install grab bars, remove loose rugs, use nightlights, and consider a stair‑lift.
• Assistive devices: Weighted utensils, voice‑activated smart devices, and mobility aids.
• Medication organization: Pillboxes, alarms, or smartphone reminders.
• Nutrition: Small, frequent meals; high‑protein, high‑calorie shakes if swallowing is difficult.
• Social engagement: Support groups (e.g., Huntington’s Disease Society of America) and community activities.
• Advance care planning: Discuss directives, power of attorney, and living wills early while decision‑making capacity is intact.

Caregiver Support

Caregivers experience high physical and emotional strain. Resources include respite care, counseling, and organizations that provide education and financial assistance.

Prevention

Because HD is a genetic disorder, primary prevention is not possible for those who already carry the mutation. However, risk reduction strategies include:

• Genetic counseling: Couples with a family history can discuss reproductive options (pre‑implantation genetic diagnosis, donor gametes).
• Avoidance of environmental neurotoxins: While not proven to cause HD, limiting exposure to pesticides and heavy metals supports overall brain health.
• Healthy lifestyle: Regular exercise and a nutrient‑dense diet may delay onset in carriers, as suggested by observational studies.<sup>[3] WHO, 2021</sup>

Complications

If untreated or poorly managed, HD can lead to serious complications:

• Falls and fractures: Due to chorea, ataxia, and impaired balance.
• Pneumonia: Aspiration from dysphagia is a leading cause of death.
• Severe depression or suicidal ideation: Reported in up to 30 % of patients.
• Malnutrition and weight loss: Contribute to frailty.
• Cardiac arrhythmias: Autonomic dysfunction may affect heart rhythm.
• Legal and financial issues: Cognitive decline can impair judgment, necessitating guardianship.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Huntington Disease Fact Sheet. Updated 2023.
2. National Institutes of Health. Genetic Testing Registry – Huntington disease. Accessed 2024.
3. World Health Organization. Lifestyle factors and neurodegenerative disease. WHO Report 2021.
4. Mayo Clinic. Huntington disease – Symptoms and causes. 2024.
5. Cleveland Clinic. Huntington disease treatment options. 2023.

```